Equity Capital And Reserves Cambiamento Data
ALKERMES USD 1.36B 75.15M 2023-09
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amarin USD 553.15M 15.98M 2023-09
ANI Pharmaceuticals USD 457.6M 2.89M 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
Eisai JPY 861.67B 16.8B 2023-09
Emergent BioSolutions USD 956.3M 246.3M 2023-06
Esperion Therapeutics USD -410004000 38.03M 2023-09
GlaxoSmithKline GBP 13.13B 442M 2023-09
Heron Therapeutics USD -27786000 11.5M 2023-09
Insmed USD -331923000 42.57M 2023-12
Ligand Pharmaceuticals USD 700.91M 33.02M 2023-12
Merck USD 41.25B 2.55B 2023-09
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Omeros USD -13952000 34.46M 2023-09
Pacira USD 870.13M 38.58M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Surmodics USD 119.91M 7.5M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Veracyte USD 1.04B 9.96M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Heron Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.